UNSPSC 51401519: Ethyl loflazepate

This classification denotes a benzodiazepine with the molecular formula C18H14ClFN2O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier VJB5FW9W9J, chemically known as 1h-1,4-benzodiazepine-3-carboxylic acid, 7-chloro-5-(2-fluorophenyl)-2,3-dihydro but generally known as ethyl loflazepate, which bears US NIH Compound Identifier 3299. European Medicines Agency schedules Ethyl loflazepate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07290MIG.

UNSPSC 51401519 Ethyl loflazepate is a Commodity code that in recent state and local procurement appears to cover pharmaceutical and medical products used in emergency response and community health settings. The single recent opportunity in the source—Seminole County, Florida's IFB for naloxone and drug deactivation systems—does not align with the code's nominal scope of a specific benzodiazepine compound. State and local procurement offices appear to use this code sparingly or misalign solicitations to it; the available activity does not confirm that ethyl loflazepate itself is being actively procured under this code at the state and local level. The opportunity shows that county health departments do purchase emergency pharmaceutical supplies and medical equipment through IFB and competitive bidding processes, with standard compliance requirements including E-Verify, drug-free workplace certification, insurance, and federal compliance riders when FEMA funding applies.

Seminole County, Florida posted the sole recent opportunity on June 30, 2026, with a response deadline of July 26, 2023 (note: the due date predates the posting date in the source, indicating a data anomaly). The procurement sought 1,900 units of naloxone and 800 safe drug deactivation systems annually for quarterly delivery to the Seminole County Community Health Building in Sanford, Florida, with a two-year initial term and one-year renewal option. Given the mismatch between the code's stated scope and the actual solicitation, this code shows limited recent relevant activity for vendors focused on ethyl loflazepate or related benzodiazepine products; further market research would be necessary to validate whether active demand exists for this specific pharmaceutical under this or related UNSPSC codes.